Multiple studies have shown that directly stimulating the cGAS-STING axis in the tumor microenvironment results in significant tumor regression and more effective immune responses across a variety of tumor models, suggesting that the cGAS-STING pathway holds promise as a healing target for liver cancer treatment (36). This evidence concerns the gene STING1 and neoplasm.